|
1
|
Miyakis S, Lockshin MD, Atsumi T, et al:
International consensus statement on an update of the
classification criteria for definite antiphospholipid syndrome
(APS). J Thromb Haemost. 4:295–306. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Silver RM, Porter TF, van Leeuween I, Jeng
G, Scott JR and Branch DW: Anticardiolipin antibodies: clinical
consequences of ‘low titers’. Obstet Gynecol. 87:494–500. 1996.
|
|
3
|
Levine SR, Salowich-Palm L, Sawaya KL, et
al: IgG anticardiolipin antibody titer > 40 GPL and the risk of
subsequent thrombo-occlusive events and death. A prospective cohort
study. Stroke. 28:1660–1665. 1997.
|
|
4
|
Erkan D, Barbhaiya M, George D,
Sammaritano L and Lockshin M: Moderate versus high-titer
persistently anticardiolipin antibody positive patients: are they
clinically different and does high-titer anti-beta 2-glycoprotein-I
antibody positivity offer additional predictive information? Lupus.
19:613–619. 2010. View Article : Google Scholar
|
|
5
|
Tuhrim S, Rand JH, Wu XX, et al: Elevated
anticardiolipin antibody titer is a stroke risk factor in a
multiethnic population independent of isotype or degree of
positivity. Stroke. 30:1561–1565. 1999. View Article : Google Scholar
|
|
6
|
Bakimer R, Fishman P, Blank M, Sredni B,
Djaldetti M and Shoenfeld Y: Induction of primary antiphospholipid
syndrome in mice by immunization with a human monoclonal
anticardiolipin antibody (H-3). J Clin Invest. 89:1558–1563. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pierangeli SS and Harris EN: Induction of
phospholipid-binding antibodies in mice and rabbits by immunization
with human beta 2 glycoprotein 1 or anticardiolipin antibodies
alone. Clin Exp Immunol. 93:269–272. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krause I, Blank M, Levi Y, Koike T, Barak
V and Shoenfeld Y: Anti-idiotype immunomodulation of experimental
anti-phospholipid syndrome via effect on Th1/Th2 expression. Clin
Exp Immunol. 117:190–197. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fischer K, Collins H, Taniguchi M,
Kaufmann SH and Schaible UE: IL-4 and T cells are required for the
generation of IgG1 isotype antibodies against cardiolipin. J
Immunol. 168:2689–2694. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Soltesz P, Der H, Veres K, et al:
Immunological features of primary anti-phospholipid syndrome in
connection with endothelial dysfunction. Rheumatology (Oxford).
47:1628–1634. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Karakantza M, Theodorou GL, Meimaris N, et
al: Type 1 and type 2 cytokine-producing CD4+ and CD8+ T cells in
primary antiphospholipid syndrome. Ann Hematol. 83:704–711.
2004.
|
|
12
|
Amital H, Gilburd B and Shoenfeld Y:
Probiotic supplementation with Lactobacillus casei (Actimel)
induces a Th1 response in an animal model of antiphospholipid
syndrome. Ann N Y Acad Sci. 1110:661–669. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Visvanathan S and McNeil HP: Cellular
immunity to beta 2-glycoprotein-1 in patients with the
antiphospholipid syndrome. J Immunol. 162:6919–6925.
1999.PubMed/NCBI
|
|
14
|
Fu J, Fy Q and Si CP: Changes of CD4+CD25+
regulatory T cells and foxp3 expression in rats with experimental
anti-phospholipid antibody syndrome. Matern Child Healthcare Chin.
25:821–824. 2010.
|
|
15
|
Lin H, Mosmann TR, Guilbert L,
Tuntipopipat S and Wegmann TG: Synthesis of T helper 2-type
cytokines at the maternal-fetal interface. J Immunol.
151:4562–4573. 1993.PubMed/NCBI
|
|
16
|
Marzi M, Vigano A, Trabattoni D, et al:
Characterization of type 1 and type 2 cytokine production profile
in physiologic and pathologic human pregnancy. Clin Exp Immunol.
106:127–133. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sugiura-Ogasawara M, Furukawa TA, Nakano
Y, Hori S, Aoki K and Kitamura T: Depression as a potential causal
factor in subsequent miscarriage in recurrent spontaneous aborters.
Hum Reprod. 17:2580–2584. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yokoo T, Takakuwa K, Ooki I, Kikuchi A,
Tamura M and Tanaka K: Alteration of TH1 and TH2 cells by
intracellular cytokine detection in patients with unexplained
recurrent abortion before and after immunotherapy with the
husband’s mononuclear cells. Fertil Steril. 85:1452–1458.
2006.PubMed/NCBI
|
|
19
|
Bonelli M, Savitskaya A, von Dalwigk K, et
al: Quantitative and qualitative deficiencies of regulatory T cells
in patients with systemic lupus erythematosus (SLE). Int Immunol.
20:861–868. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Behrens F, Himsel A, Rehart S, et al:
Imbalance in distribution of functional autologous regulatory T
cells in rheumatoid arthritis. Ann Rheum Dis. 66:1151–1156. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Qian L, Wang G, et al: T regulatory
cells are markedly diminished in diseased salivary glands of
patients with primary Sjogren’s syndrome. J Rheumatol.
34:2438–2445. 2007.PubMed/NCBI
|
|
22
|
Dalla Libera D, Di Mitri D, Bergami A, et
al: T regulatory cells are markers of disease activity in multiple
sclerosis patients. PLoS One. 6:e213862011.PubMed/NCBI
|
|
23
|
Miyara M, Gorochov G, Ehrenstein M, Musset
L, Sakaguchi S and Amoura Z: Human FoxP3+ regulatory T cells in
systemic autoimmune diseases. Autoimmun Rev. 10:744–755. 2011.
|
|
24
|
Sasaki Y, Sakai M, Miyazaki S, Higuma S,
Shiozaki A and Saito S: Decidual and peripheral blood CD4+CD25+
regulatory T cells in early pregnancy subjects and spontaneous
abortion cases. Mol Hum Reprod. 10:347–353. 2004.
|
|
25
|
Fraccaroli L, Alfieri J, Larocca L, et al:
A potential tolerogenic immune mechanism in a trophoblast cell line
through the activation of chemokine-induced T cell death and
regulatory T cell modulation. Hum Reprod. 24:166–175. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Arruvito L, Sotelo AI, Billordo A and
Fainboim L: A physiological role for inducible FOXP3(+) Treg cells.
Lessons from women with reproductive failure. Clin Immunol.
136:432–441. 2010.
|
|
27
|
McKenzie BS, Kastelein RA and Cua DJ:
Understanding the IL-23-IL-17 immune pathway. Trends Immunol.
27:17–23. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Steinman L: A brief history of T(H)17, the
first major revision in the T(H)1/T(H)2 hypothesis of T
cell-mediated tissue damage. Nat Med. 13:139–145. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang WJ, Hao CF, Qu QL, Wang X, Qiu LH and
Lin QD: The deregulation of regulatory T cells on
interleukin-17-producing T helper cells in patients with
unexplained early recurrent miscarriage. Hum Reprod. 25:2591–2596.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu YS, Wu L, Tong XH, et al: Study on the
relationship between Th17 cells and unexplained recurrent
spontaneous abortion. Am J Reprod Immunol. 65:503–511. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nakashima A, Ito M, Shima T, Bac ND,
Hidaka T and Saito S: Accumulation of IL-17-positive cells in
decidua of inevitable abortion cases. Am J Reprod Immunol. 64:4–11.
2010.PubMed/NCBI
|
|
32
|
Ogura H, Murakami M, Okuyama Y, et al:
Interleukin-17 promotes autoimmunity by triggering a
positive-feedback loop via interleukin-6 induction. Immunity.
29:628–636. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ferrara DE, Swerlick R, Casper K, et al:
Fluvastatin inhibits up-regulation of tissue factor expression by
antiphospholipid antibodies on endothelial cells. J Thromb Haemost.
2:1558–1563. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mulla MJ, Brosens JJ, Chamley LW, et al:
Antiphospholipid antibodies induce a pro-inflammatory response in
first trimester trophoblast via the TLR4/MyD88 pathway. Am J Reprod
Immunol. 62:96–111. 2009. View Article : Google Scholar : PubMed/NCBI
|
